OBJECTIVE: Resolution of low-grade inflammation of white adipose tissue (WAT) is one of the keys for amelioration of obesity-associated metabolic dysfunctions. We focused on the identification of adipokines, which could be involved at the early stages of resolution of WAT inflammation. METHODS AND PROCEDURE: Male C57BL/6J mice with obesity induced in response to a 22-week feeding corn oil-based high-fat (cHF) diet were divided into four groups and were fed with, for 2 weeks, control cHF diet or cHF-based diets supplemented with: (i) concentrate of n-3 long-chain polyunsaturated fatty acids, mainly eicosapentaenoic and docosahexaenoic acids (cHF+F); (ii) thiazolidinedione drug rosiglitazone (cHF+TZD); and (iii) both compounds (cHF+F+TZD). RESULTS: The short-term combined intervention exerted additive effect in the amelioration of WAT inflammation in obese mice, namely in the epididymal fat, even in the absence of any changes in either adipocyte volume or fat mass. The combined intervention elicited hypolipidaemic effect and induced adiponectin, whereas the responses to single interventions (cHF+F, cHF+TZD) were less pronounced. In addition, analysis in WAT lysates using protein arrays revealed that the levels of a small set of adipose tissue-related proteins, namely macrophage inflammatory protein 1γ, endoglin, vascular cell adhesion molecule 1 and interleukin 1 receptor antagonist, changed in response to the anti-inflammatory interventions and were strongly reduced in the cHF+F+TZD mice. These results were verified using both the analysis of gene expression and enzyme-linked immunosorbent analysis in WAT lysates. In contrast with adiponectin, which showed changing plasma levels in response to dietary interventions, the levels of the above proteins were affected only in WAT. CONCLUSIONS: We identified several adipose tissue-related proteins, which are locally involved in resolution of low-grade inflammation and remodelling of WAT.
OBJECTIVE: Resolution of low-grade inflammation of white adipose tissue (WAT) is one of the keys for amelioration of obesity-associated metabolic dysfunctions. We focused on the identification of adipokines, which could be involved at the early stages of resolution of WAT inflammation. METHODS AND PROCEDURE: Male C57BL/6J mice with obesity induced in response to a 22-week feeding corn oil-based high-fat (cHF) diet were divided into four groups and were fed with, for 2 weeks, control cHF diet or cHF-based diets supplemented with: (i) concentrate of n-3 long-chain polyunsaturated fatty acids, mainly eicosapentaenoic and docosahexaenoic acids (cHF+F); (ii) thiazolidinedione drug rosiglitazone (cHF+TZD); and (iii) both compounds (cHF+F+TZD). RESULTS: The short-term combined intervention exerted additive effect in the amelioration of WAT inflammation in obesemice, namely in the epididymal fat, even in the absence of any changes in either adipocyte volume or fat mass. The combined intervention elicited hypolipidaemic effect and induced adiponectin, whereas the responses to single interventions (cHF+F, cHF+TZD) were less pronounced. In addition, analysis in WAT lysates using protein arrays revealed that the levels of a small set of adipose tissue-related proteins, namely macrophage inflammatory protein 1γ, endoglin, vascular cell adhesion molecule 1 and interleukin 1 receptor antagonist, changed in response to the anti-inflammatory interventions and were strongly reduced in the cHF+F+TZDmice. These results were verified using both the analysis of gene expression and enzyme-linked immunosorbent analysis in WAT lysates. In contrast with adiponectin, which showed changing plasma levels in response to dietary interventions, the levels of the above proteins were affected only in WAT. CONCLUSIONS: We identified several adipose tissue-related proteins, which are locally involved in resolution of low-grade inflammation and remodelling of WAT.
Authors: H Kim; M Haluzik; O Gavrilova; S Yakar; J Portas; H Sun; U B Pajvani; P E Scherer; D LeRoith Journal: Diabetologia Date: 2004-12-15 Impact factor: 10.122
Authors: Anna M Wolf; Dominik Wolf; Holger Rumpold; Barbara Enrich; Herbert Tilg Journal: Biochem Biophys Res Commun Date: 2004-10-15 Impact factor: 3.575
Authors: Martin Rossmeisl; Zuzana Macek Jilkova; Ondrej Kuda; Tomas Jelenik; Dasa Medrikova; Barbora Stankova; Björn Kristinsson; Gudmundur G Haraldsson; Harald Svensen; Iren Stoknes; Peter Sjövall; Ylva Magnusson; Michiel G J Balvers; Kitty C M Verhoeckx; Eva Tvrzicka; Morten Bryhn; Jan Kopecky Journal: PLoS One Date: 2012-06-11 Impact factor: 3.240
Authors: Olga Horakova; Dasa Medrikova; Evert M van Schothorst; Annelies Bunschoten; Pavel Flachs; Vladimir Kus; Ondrej Kuda; Kristina Bardova; Petra Janovska; Michal Hensler; Martin Rossmeisl; Rui Wang-Sattler; Cornelia Prehn; Jerzy Adamski; Thomas Illig; Jaap Keijer; Jan Kopecky Journal: PLoS One Date: 2012-08-31 Impact factor: 3.240
Authors: Raymond E Soccio; Zhenghui Li; Eric R Chen; Yee Hoon Foong; Kiara K Benson; Joanna R Dispirito; Shannon E Mullican; Matthew J Emmett; Erika R Briggs; Lindsey C Peed; Richard K Dzeng; Carlos J Medina; Jennifer F Jolivert; Megan Kissig; Satyajit R Rajapurkar; Manashree Damle; Hee-Woong Lim; Kyoung-Jae Won; Patrick Seale; David J Steger; Mitchell A Lazar Journal: J Clin Invest Date: 2017-02-27 Impact factor: 14.808
Authors: Kathleen M Hertzer; Mu Xu; Aune Moro; David W Dawson; Lin Du; Gang Li; Hui-Hua Chang; Alexander P Stark; Xiaoman Jung; Oscar Joe Hines; Guido Eibl Journal: Pancreas Date: 2016-03 Impact factor: 3.327